CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis
€ 15.50 · 4.6 (412) · Auf Lager
Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by
4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces
CaMKII Gamma antibody (12666-2-AP)
EZH2 noncanonically binds cMyc and p300 through a cryptic
IJMS, Free Full-Text
Recent advances in targeting the “undruggable” proteins: from drug
Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib
4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces
Frontiers Deregulated calcium signaling in blood cancer
How selective are clinical CDK4/6 inhibitors? - Hendrychová - 2021
Frontiers Deregulated calcium signaling in blood cancer
